163 related articles for article (PubMed ID: 37293256)
21. Clinical characteristics and management differences for grade II and III spinal meningiomas.
Krauss WE; Yolcu YU; Alvi MA; Moinuddin FM; Goyal A; Clarke MJ; Marsh WR; Bydon M
J Neurooncol; 2021 Jun; 153(2):313-320. PubMed ID: 33973145
[TBL] [Abstract][Full Text] [Related]
22. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
23. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
24. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
[TBL] [Abstract][Full Text] [Related]
25. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
26. Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07).
Deng MY; da Silva AS; Göller PC; König L; Schäfer H; Maire C; Lentz-Hommertgen A; Held T; Regnery S; Eichkorn T; Stritzke F; Bauer L; Schnell D; Herfarth K; von Deimling A; Krieg S; Wick A; Wick W; Grosu A; Debus J; Sahm F; Ricklefs F
BMC Cancer; 2024 Apr; 24(1):449. PubMed ID: 38605332
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
28. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
Marciscano AE; Stemmer-Rachamimov AO; Niemierko A; Larvie M; Curry WT; Barker FG; Martuza RL; McGuone D; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2016 Jan; 124(1):106-14. PubMed ID: 26274991
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
31. WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.
Champeaux C; Wilson E; Shieff C; Khan AA; Thorne L
J Neurooncol; 2016 Sep; 129(2):337-45. PubMed ID: 27311726
[TBL] [Abstract][Full Text] [Related]
32. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Raleigh D; Chen W; Choudhury A; Youngblood M; Polley MY; Lucas CH; Mirchia K; Maas S; Suwala A; Won M; Bayley J; Harmanci A; Harmanci A; Klisch T; Nguyen M; Vasudevan H; McCortney K; Yu T; Bhave V; Lam TC; Pu J; Leung G; Chang J; Perlow H; Palmer J; Haberler C; Berghoff A; Preusser M; Nicolaides T; Mawrin C; Agnihotri S; Resnick A; Rood B; Chew J; Young J; Boreta L; Braunstein S; Schulte J; Butowski N; Santagata S; Spetzler D; Bush NAO; Villanueva-Meyer J; Chandler J; Solomon D; Rogers C; Pugh S; Mehta M; Sneed P; Berger M; Horbinski C; McDermott M; Perry A; Bi W; Patel A; Sahm F; Magill S
Res Sq; 2023 Mar; ():. PubMed ID: 36993741
[TBL] [Abstract][Full Text] [Related]
33. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
34. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
35. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy.
Klinger DR; Flores BC; Lewis JJ; Hatanpaa K; Choe K; Mickey B; Barnett S
World Neurosurg; 2015 Sep; 84(3):839-45. PubMed ID: 25916182
[TBL] [Abstract][Full Text] [Related]
36. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
37. Major complications from radiotherapy following treatment for atypical meningiomas.
Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
40. WHO grade II meningioma: Epidemiology, survival and contribution of postoperative radiotherapy in a multicenter cohort of 88 patients.
Poulen G; Vignes JR; Le Corre M; Loiseau H; Bauchet L
Neurochirurgie; 2020 Apr; 66(2):73-79. PubMed ID: 32145249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]